June 5, 2017 by Greg Jacobson and Chain Drug Review
Centers for Disease Control and Prevention, cuts in health care, Department of Health and Human Services, fiscal 2018 U.S. budget, Food and Drug Administration, Mick Mulvaney, National Institutes of Health
2017, Issue 06-05-2017, Issues, News
WASHINGTON — The fiscal 2018 U.S. budget issued by the Trump administration calls for steep cuts in health care and scientific research while heavily boosting defense spending and offering substantial tax cuts. Dubbed “A New Foundation for American Greatness,” the spending plan was touted as a “taxpayer first” budget by Mick Mulvaney, director of the
July 25, 2016 by Brian Bossetta
Alex Gourlay, National Institutes of Health, PMI Cohort Program, USA Precision Medicine Initiative, Walgreens, Walgreens Boots Alliance, WBA
2016, Issue 07-25-2016, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) is participating in the USA Precision Medicine Initiative (PMI) Cohort Program. WBA said its participation is the result of a $20 million grant awarded to The Scripps Research Institute by the National Institutes of Health (NIH). Walgreens will help support patient enrollment and participation in the cohort
July 8, 2016 by Chain Drug Review
Alex Gourlay, Brad Fluegel, FDA, Food and Drug Administration, National Institutes of Health, next-generation sequencing, Precision Medicine Initiative, Precision Medicine Initiative Cohort Program, Robert Califf, Walgreens, Walgreens Boots Alliance
Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens plans to participate in the U.S. Precision Medicine Initiative Cohort Program, part of a sweeping federal medical research initiative to help develop individualized care based on a person’s genomic makeup. Walgreens said it’s taking part in the PMI Cohort Program via an initial $20 million grant awarded to The Scripps Research
January 4, 2016 by John Schultz and Chain Drug Review
Affordable Care Act, David French, Francis Collins, health care industry, health insurance, National Institutes of Health, National Retail Federation
2016, Issue 01-04-2016, Issues, News
WASHINGTON — Republican opponents of President Obama’s health care law may do better by dismantling the Affordable Care Act piece by piece. Under the budget deal passed by Congress and signed by the president last month, a widely criticized tax on high-cost employer health insurance plans has been delayed and two taxes already being collected
February 16, 2015 by Mark Baumgartner and Chain Drug Review
Food and Drug Administration, Francis Collins, Generic Pharmaceutical Association, Margaret Hamburg, National Institutes of Health, Ralph Neas, Stephen Ostroff
2015, Issue 02-16-2015, News, Pharmacy
WASHINGTON — Dr. Margaret Hamburg, commissioner of the Food and Drug Administration, will step aside next month after nearly six years at the helm of the agency overseeing many of the nation’s most contentious public policy issues and products representing about 20% of every dollar spent by consumers. Hamburg, 59, said her decision to step